Browse Drug Recalls
1,720 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,720 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,720 FDA drug recalls, Class III.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 28, 2015 | Dexmethylphenidate HCl Extended-Release, Capsules, 10mg, Rx only, 100 Capsule... | Failed Dissolution Specifications: Product is being recalled due to out of specification (above s... | Class III | Novartis Pharmaceuticals Corp. |
| Jul 28, 2015 | Wal-itin Loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a)... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Fred's Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-counts tablet... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | CareOne Original Prescription Strength, Allergy Relief, Loratadine Orally Dis... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | QC Quality Choice Loratadine Orally Disintegrating Tablets, USP 10 mg, 10-cou... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Health Best Choice Care, Loratadine Orally Disintegrating Tablets, USP, 10 mg... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Major loratadine orally disintegrating tablets, USP, 10 mg, 10-count tablets ... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Good Neighbor Pharmacy Loratadine Orally Disintegrating Tablets, USP, 10 mg, ... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets ... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | CVS Pharmacy, Original Prescription Strength, LORATADINE ORALLY DISINTEGRATIN... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Rite Aid Pharmacy loratadine orally disintegrating tablets USP, 10 mg, packag... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Equaline Original Prescription Strength, loratadine orally disintegrating tab... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 28, 2015 | Premier Value Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count ... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
| Jul 24, 2015 | Nisoldipine Extended Release Tablets, 17 mg, packaged as a) Sular (nisoldipi... | Failed Dissolution Specifications | Class III | Shionogi Inc. |
| Jul 21, 2015 | Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bott... | Failed Dissolution Specification: One lot of product did not meet the first stage dissolution spe... | Class III | Apotex Inc. |
| Jul 21, 2015 | Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 7-count (NDC ... | Failed impurities/Degradation specifications: out of specification results for individual unknown... | Class III | PD-Rx Pharmaceuticals, Inc. |
| Jul 20, 2015 | ALLOPURINOL TABLETS, USP, 300 mg, 500 count bottle, Rx only, Manufactured for... | Failed Tablet/Capsule Specifications; report of oversized and discolored tablets | Class III | Qualitest Pharmaceuticals |
| Jul 17, 2015 | buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-... | Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it... | Class III | Sun Pharma Global Fze |
| Jul 16, 2015 | Felodipine Extended-Release Tablets, 2.5 mg, 100 count bottles, Rx only, Mutu... | Chemical Contamination; benzophenone leached from the product label varnish | Class III | Mutual Pharmaceutical Company, Inc. |
| Jul 16, 2015 | Felodipine Extended-Release Tablets, 10 mg, 100 count bottles, Rx only, Mutua... | Chemical Contamination; benzophenone leached from the product label varnish | Class III | Mutual Pharmaceutical Company, Inc. |
| Jul 16, 2015 | Felodipine Extended-Release Tablets, 5 mg, 100 count bottles, Rx only, Mutu... | Chemical Contamination; benzophenone leached from the product label varnish | Class III | Mutual Pharmaceutical Company, Inc. |
| Jul 16, 2015 | Imipramine HCl Tablets, USP, 50 mg, 100 count bottles, Mfd By: Mutual Pharmac... | Chemical Contamination; benzophenone leached from the product label varnish | Class III | Mutual Pharmaceutical Company, Inc. |
| Jul 16, 2015 | Imipramine HCl Tablets, USP, 25 mg, 100 count bottles, Mfd By: Mutual Pharmac... | Chemical Contamination; benzophenone leached from the product label varnish | Class III | Mutual Pharmaceutical Company, Inc. |
| Jul 16, 2015 | Imipramine HCl Tablets, USP, 10 mg, 100 count bottles, Rx only, Mfd By: Mutua... | Chemical Contamination; benzophenone leached from the product label varnish | Class III | Mutual Pharmaceutical Company, Inc. |
| Jul 14, 2015 | Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 100-count bott... | Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown... | Class III | KVK-Tech, Inc. |
| Jul 13, 2015 | Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by P... | Subpotent drug | Class III | Perrigo Israel Pharmaceuticals |
| Jul 13, 2015 | Intermezzo (zolpidem tartrate), sublingual tablet 3.5 mg, 1 tablet per pouch,... | Failed dissolution specifications | Class III | Purdue Pharma L.P. |
| Jul 6, 2015 | Maximum Strength Analgesic Thera-Gesic Pain Relieving Creme Relief from: Join... | Subpotent Drug: menthol and methyl salicylate below specification | Class III | BioComp Pharma, Inc. |
| Jul 2, 2015 | CVS SUGAR FREE BLACK CHERRY COUGH DROPS (MENTHOL-COUGH SUPPRESSANT), Packaged... | Presence of Foreign Tablets/Capsules: Presence of comingled Sugar Free Honey Lemon cough drops. | Class III | Bestco, Inc. |
| Jun 30, 2015 | Panadol (acetaminophen) Extra Strength, 500 mg, a) 30 count (UPC 1-03-53100-9... | Failed Dissolution Specifications | Class III | GlaxoSmithkline Consmer Healthcare |
| Jun 29, 2015 | HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3... | Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable | Class III | Qualitest Pharmaceuticals |
| Jun 26, 2015 | Desmopressin Acetate Tablets, 0.1 mg Tablets, Rx Only, Packed in 30 Tablet (3... | Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side. | Class III | American Health Packaging |
| Jun 26, 2015 | METOCLOPRAMIDE ORAL SOLUTION, USP 10 mg/10 mL, 10 mL cups, Rx only. Manufactu... | Defective Container: Lids on unit dose cups are not fully qualified. | Class III | VistaPharm, Inc. |
| Jun 23, 2015 | Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only. Manufactured... | Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side. | Class III | Actavis Laboratories, FL, Inc. |
| Jun 23, 2015 | CORTISOL-MC, 10mg CAP, packaged in 30 and 90 count bottles, Rx Only, ABRAMS R... | Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications. | Class III | Abrams Royal Pharmacy II, LLC |
| Jun 18, 2015 | Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for... | Failed Dissolution Specifications: During routine stability testing at the 12 month time point, ... | Class III | Qualitest Pharmaceuticals |
| Jun 5, 2015 | Carb-O-Philic 40 Cream, 40%, a) 3 oz. tube (NDC 54162-640-03) b) 7 oz. tube (... | CGMP Deviation: Poor container closure of the bulk storage container | Class III | Geritrex Corp |
| Jun 4, 2015 | Dr Blue Pain Relieving Gel, (4.6% menthol), For temporary relief of minor ach... | Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of t... | Class III | Indiana Botanic Gardens, Inc |
| Jun 4, 2015 | Lutera (0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol tablets USP), 28 ... | Labeling: Incorrect or Missing Package Insert; Product is being recalled because the birth contro... | Class III | Actavis Inc |
| May 27, 2015 | E-Z-CAT Dry Barium Sulfate for Suspension (2% w/w after mixing), 23 g foil po... | Failed stability specifications:This recall has been initiated due to out of specification result... | Class III | Bracco Diagnostic Inc |
| May 22, 2015 | Foradil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule,... | Failed Stability Specification: out of specification result obtained for the Particle Size Distri... | Class III | Novartis Pharmaceuticals Corp. |
| May 22, 2015 | Foradil Aerolizer (formoterol fumarate inhalation powder) 12 mcg per capsule,... | Failed Stability Specification: out of specification result obtained for the Particle Size Distri... | Class III | Novartis Pharmaceuticals Corp. |
| May 19, 2015 | Magnesium Sulfate Injection, USP, 50%, 20mL, Single dose Fliptop Vial, For IV... | Failed pH Specifications: 12 month stability testing | Class III | Hospira Inc. |
| May 13, 2015 | Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL), Rx On... | Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548). | Class III | West-Ward Pharmaceutical Corp. |
| May 7, 2015 | QVAR (beclomethasone dipropionate HFA 40 mcg), 40 mcg Inhalation Aerosol, For... | Failed Impurities/Degradation Specifications: out of specification test results for an impurity d... | Class III | Teva Pharmaceuticals USA |
| May 6, 2015 | Amlodipine besylate and Atorvastatin calcium tablets, 5mg/10mg, packaged in a... | Subpotent drug | Class III | Dr. Reddy's Laboratories, Inc. |
| May 6, 2015 | Amlodipine besylate and Atorvastatin calcium tablets, 10mg/10mg, packaged in ... | Subpotent drug | Class III | Dr. Reddy's Laboratories, Inc. |
| May 6, 2015 | Amlodipine besylate and Atorvastatin calcium tablets, 10mg/40mg, 90-count bot... | Subpotent drug | Class III | Dr. Reddy's Laboratories, Inc. |
| May 6, 2015 | Amlodipine besylate and Atorvastatin calcium tablets, 5mg/40mg packaged in a)... | Subpotent drug | Class III | Dr. Reddy's Laboratories, Inc. |
| May 4, 2015 | Loratadine Orally Disintegrating Tablets USP, 10 mg, Antihistamine, Allergy R... | Superpotent Drug: Out Of Specification (OOS) result for Assay. | Class III | Ohm Laboratories, Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.